Find your path to Laurence
162 people in our graph share verified history with Laurence — schools, employers, funds. One of them is your warm intro.
Jyri EngeströmunlockedLaurence: together at Université de Montréal (1998)
×7Laurence: together at Université de Montréal
Laurence: together at Epitopea
Laurence: together at adMare BioInnovations
About
Laurence Rulleau, a PhD-trained biologist and former life sciences equity analyst, uniquely originates and builds companies around assets, having led creation of Dalcor, Ilkos, Precithera, Find Therapeutics and Epitopea.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Experience
- Domain TherapeuticsChairwoman of the Boardcurrent2022 — present
- EpitopeaChairwoman of the Boardcurrent2021 — present
- CTI Life Sciences FundManaging Partner at CTI LSF IIIcurrent2020 — present
- CTI Life Sciences FundPartner at CTI LSF II2014 — 2020Montreal, Quebec, Canada
- Find TherapeuticsBoard Membercurrent2020 — presentMontreal, Quebec, Canada
- DalCor PharmaceuticalsMember Board Of Directorscurrent2016 — presentGreater Montreal Metropolitan Area
- adMare BioInnovationsBOD member2019 — 2025Vancouver, British Columbia, Canada
- ILKOS THERAPEUTICS Inc.Board Observer2017 — 2020Greater Montreal Metropolitan Area
- PreciThera, Inc.BOD member2017 — 2020Montreal, Quebec, Canada
- CDRDBOD Member2018 — 2019Vancouver, British Columbia, Canada
- Visterra Inc.Board Observer2017 — 2019Greater Boston
- NEOMED InstituteChair Of The Board Of Directors2017 — 2019Greater Montreal Metropolitan Area
- NEOMED InstituteMember of the Board of Directors2015 — 2019Greater Montreal Metropolitan Area
- Societe de Gestion Centre d'excellence en thérapie cellulaireMember of Board of Directors2012 — 2017Greater Montreal Metropolitan Area
- Gestion UnivalorVice-President Business Development2011 — 2014Greater Montreal Metropolitan Area
- Merieux developpementVenture Partner2010 — 2011
- HLA-G TechnologiesCEO2008 — 2010
- Blackmont CapitalBiotechnology analyst2006 — 2008
- Orion securitiesBiotechnology analyst2005 — 2006
- Desjardins securitiesVice-President biotechnology2003 — 2006
- YORKTON SECURITIES INCBiotechnology analyst2000 — 2003
- Banque Laurentienne securitiesBiotechnology analyst1998 — 2000
Skills & more
Strategy5Biotechnology39Venture Capital18Lifesciences25Pharmaceutical Industry24Technology Transfer8Commercialization10Biopharmaceuticals2Business Development14Drug Discovery4Entrepreneurship5Drug Development8
+11 more
Start-upsClinical DevelopmentBiotechnologieSciences de la vieTransfert technologiqueCapital risqueCommercialisationStratégieBusiness StrategyLicensingClinical TrialsLanguages English · french
From Laurence's professional profile.
Colleagues at CTI Life Sciences Fund L.P.
Dana Matzen
Partner at CTI Life Sciences Fund L.P.
Ken Pastor
Managing Partner at CTI Life Sciences Fund L.P.
Paul Cassar
Associate at CTI Life Sciences Fund L.P.
Radhika Gupta
Principal at CTI Life Sciences Fund L.P.
Shermaine Tiley
Managing Partner at CTI Life Sciences Fund L.P.
Shermaine Tilley
Managing Partner at CTI Life Sciences Fund L.P.
Xin Hang
Principal at CTI Life Sciences Fund L.P.
Youssef Bennani
Managing Partner at CTI Life Sciences Fund L.P.
Frequently asked questions
- Who is Laurence Rulleau?
- Laurence Rulleau, a PhD-trained biologist and former life sciences equity analyst, uniquely originates and builds companies around assets, having led creation of Dalcor, Ilkos, Precithera, Find Therapeutics and Epitopea.
- Where does Laurence Rulleau work?
- Laurence Rulleau is Managing Partner at CTI Life Sciences Fund L.P..
- What does Laurence Rulleau invest in?
- Laurence Rulleau invests in Biotech, Healthtech, Medical Devices.
- Where did Laurence Rulleau go to school?
- Laurence Rulleau studied at UQAM | Université du Québec à Montréal (Master, viro-immunology); Université de Montréal (PhD, Molecular biology).
Same school
Also attended UQAM | Université du Québec à Montréal48
Caroline RheaultFinancial Controller at Brightspark VenturesSasha LuccioniInvestor at Blue Tulip VenturesPatrick PichettePartner at Inovia CapitalGrégoire PontoizeauPrincipal at Korelya CapitalEmily HaniotisPrincipal, Investments at DiagramErnestAdvisor at Triptyq Capital
+ 42 more
Also attended Université de Montréal97
Anne-Sophie GauvinCommunications & Office Manager at Luge CapitalJyri EngeströmPartner at Lifeline VenturesRajaa GrarVenture Partner at Springdale VenturesErich SieberFounding General Partner at PeakBridge VCHenri ArslanianMember of Advisory Board at Hex TrustFrancois GrattonInvestor at AgeTech Capital
+ 91 more
Shared employers
Also worked at Domain Therapeutics1
Also worked at DalCor Pharmaceuticals2
Also worked at adMare BioInnovations7
Danielle KarakasAnalyst at Lumira VenturesNancy HarrisonVenture Partner at Amplitude Venture CapitalPatricia EscoffierPrincipal at Seido CapitalBarry GeeDirector, Public Affairs at Toronto Innovation Acceleration PartnersDavid ShinDirector, Research & Investments at DRI HealthcareParas SharmaPrincipal at BDC Fund Investments (Fund-of-Funds)
+ 1 more
